Drug Type Small molecule drug |
Synonyms- |
Target |
Mechanism DCK inhibitors(Deoxycytidine kinase inhibitors) |
Therapeutic Areas |
Active Indication- |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhaseDiscontinuedPreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC23H20FN5O2S |
InChIKeyYBTIDKMFVSZULE-HOTGVXAUSA-N |
CAS Registry1034174-88-3 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Leukemia | Preclinical | - | - | |
Lymphoma | Preclinical | - | - |